Talking Medicines
PrivateLast Round
Convertible Debt
May 26, 2026
Est. Valuation
$10.15M
Total Funding Raised
$5.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Talking Medicines is a healthtech company that provides a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launched medicines.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, NLP & Conversational AI, Patient Engagement, Medical AI, Marketing
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Talking Medicines Comparables
Compare Talking Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Swoop | 74% | |
| IQVIA Holdings Inc. | 70% | |
| Cegedim | 63% |
Talking Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 26, 2026 | ||||
| Convertible Debt | Feb 1, 2024 | ||||
| Seed | Feb 1, 2022 | ||||
| Seed | Nov 5, 2020 | ||||
| Seed | May 13, 2019 | ||||
Grant | Aug 28, 2017 |
Key People
Founding team and executive leadership
Talking Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tern PLC | Convertible Debt, Seed |
| Social Investment Scotland (SIS) Ventures | Convertible Debt, Seed |
| Scottish Investment Bank (Scottish Enterprise) | Convertible Debt, Seed |
| SIS Ventures | Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 190% MoM, from 185 to 536.
- May 26, 2026
$65K round raised with Tern PLC
Recent news
Latest coverage and updates
- launchesSep 16, 2026
Talking Medicines Limited launched application, 'Intent to Prescribe' within DrugVoice platform on Sep 16th '26.
Talking Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Talking Medicines's valuation, stock price, and market status.
Is Talking Medicines a public or private company?
Talking Medicines is a private company.
What is the current stock price of Talking Medicines?
Talking Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is Talking Medicines worth (valuation)?
Talking Medicines's valuation is estimated at $10.2M based on funding round data.
Can I buy Talking Medicines stock?
Talking Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Talking Medicines's last funding round?
Talking Medicines's most recent funding round was Convertible Debt on February 1, 2022.
Who are the main investors in Talking Medicines?
Key investors in Talking Medicines include Tern PLC.
Will Talking Medicines IPO soon?
No public IPO plans have been announced for Talking Medicines.
How can I track Talking Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Talking Medicines's secondary market activity and sign up for updates.